Genomic Diagnostics improve equity of access to hereditary cancer genomic analysis in Australia with the SOPHiA DDM™ Hereditary Cancer Solution v1.1.
Genomic Diagnostics, Australia
read more
Case Studies
TomaLab Advanced Biomedical Assays
A Clinical Case Study about the value of the SOPHiA DDM™ HRD Dx Solution in clinical routine
The Andalusian Health Service use the CE IVD-marked SOPHiA DDM™️ Dx Hereditary Cancer Solution to detect an Alu insertion (Clinical Decision Support Only) in an ovarian cancer case
The SOPHiA DDM™️ Platform enables the quick and confident assessment of ~1000 hereditary cancer samples per year.
The Andalusian Health Service address a colorectal cancer case with the CE IVD-marked SOPHiA DDM™️ Dx Hereditary Cancer Solution
The CNV detection algorithm in SOPHiA DDM™️ efficiently identified a complex duplication in MSH2.
Ontario Group of Hospitals use a future-proof custom SOPHiA DDM™ Comprehensive Hereditary Cancer Solution to be in line with Ontario guidelines.
Hospitals maximize efficiency of their laboratory workflow, fulfil updated Ontario guidelines and keep testing in-house.
The Andalusian Health Service conduct trio analysis with the SOPHiA DDM™ Platform to identify the underlying cause of 2 neonatal deaths
The SOPHiA DDM Platform was a very useful tool for resolving this complex case.
Motol University Hospital in Prague discover a novel cause of inherited cardiac disease with the SOPHiA Clinical Exome Solution v3
The laboratory finds the community frequency tool very useful for making quick decisions about whether to deeply investigate a variant.
Collaborating with the Bambino Gesù Children’s Hospital to develop the SOPHiA Nephropathies Solution
SOPHiA DDM™ enables the laboratory to process a large number of samples in a simple way to gain exhaustive insights.
DASA leverages on the SOPHiA GENETICS multimodal approach in the fight against cancer
SOPHiA GENETICS is Dasa’s partner of choice for data-driven medicine utilizing a multimodal data approach and SOPHiA DDM Trial Match.
Indian research hospital chose SOPHiA DDM™ for the analysis of gene fusion events
SOPHiA DDM™’s unique community frequency tool helps to assess solid tumor variant frequency in the hospital’s cohort and globally.
University of Sassari adopts SOPHiA DDM™ for SARS-CoV-2 research and surveillance
SOPHiA DDM™ saves the reference center a massive amount of data analysis time so they can focus more on interpretation.